10x Genomics Inc (TXG): Next-Year EPS Estimate 25.16%
As of 2026-05-07, 10x Genomics Inc (TXG) has a next-year EPS growth estimate of 25.16%.
On 2026-05-06, analyst consensus for TXG's next-year EPS growth shifted from 25.51% to 25.16% — a negative change of 0.35 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -157.43%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Health Information Services
- EPS growth next year
- 25.16%
- EPS growth this year
- -157.43%
- EPS next quarter (est)
- -$0.28
- Last price
- $22.42
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-07 | 25.16% | -157.43% | -$0.28 | $22.42 |
| 2026-05-06 | 25.16% | -157.43% | -$0.28 | $22.74 |
| 2026-05-05 | 25.51% | -157.41% | -$0.28 | $22.01 |
| 2026-05-04 | 25.51% | -157.41% | -$0.28 | $21.65 |
| 2026-05-03 | 25.51% | -157.41% | -$0.28 | $22.43 |
| 2026-04-30 | 25.51% | -157.41% | -$0.28 | $22.05 |
| 2026-04-29 | 25.51% | -157.41% | -$0.28 | $20.20 |
| 2026-04-28 | 25.51% | -157.41% | -$0.28 | $21.37 |
| 2026-04-27 | 25.51% | -157.41% | -$0.28 | $22.28 |
| 2026-04-26 | 25.51% | -157.41% | -$0.28 | $22.08 |
| 2026-04-24 | 25.51% | -157.41% | -$0.28 | $22.08 |
| 2026-04-23 | 25.51% | -157.41% | -$0.28 | $21.42 |
| 2026-04-22 | 25.51% | -157.41% | -$0.28 | $22.83 |
| 2026-04-21 | 25.51% | -157.41% | -$0.28 | $22.97 |
| 2026-04-20 | 25.32% | -157.41% | -$0.28 | $24.59 |
| 2026-04-19 | 28.98% | -146.50% | -$0.27 | $26.08 |
| 2026-04-16 | 28.98% | -146.50% | -$0.27 | $25.24 |
| 2026-04-15 | 28.85% | -146.27% | -$0.27 | $25.35 |
| 2026-04-14 | 28.85% | -146.27% | -$0.27 | $24.80 |
| 2026-04-13 | 29.28% | -147.50% | -$0.27 | $23.58 |
| 2026-04-12 | 29.28% | -147.50% | -$0.27 | $23.27 |
| 2026-04-10 | 29.28% | -147.50% | -$0.27 | $22.84 |
| 2026-04-09 | 29.28% | -147.50% | -$0.27 | $23.00 |
| 2026-04-08 | 29.28% | N/A | -$0.27 | $23.02 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is 10x Genomics Inc's next-year EPS growth estimate?▾
As of 2026-05-07, 10x Genomics Inc (TXG) has a next-year EPS growth estimate of 25.16%, based on analyst consensus.
When was the latest EPS estimate revision for TXG?▾
The most recent revision occurred on 2026-05-06, when analysts adjusted the next-year EPS growth estimate from 25.51% to 25.16%.
What sector and industry does 10x Genomics Inc belong to?▾
10x Genomics Inc operates in the Healthcare sector, specifically the Health Information Services industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TXG appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. 10x Genomics Inc (TXG) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports